Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV002077195 | SCV005440655 | likely benign | Pitt-Hopkins syndrome | 2024-08-30 | reviewed by expert panel | curation | The highest population minor allele frequency of the p.Ser82Asn variant in TCF4 in gnomAD v2.1.1 is 0.00006 in African/African American population (not sufficient to meet BS1 criteria). The p.Ser82Asn variant is observed in at least 2 unaffected individuals (internal database - GeneDx and Invitae) (BS2). Computational analysis prediction tools suggest that the p.Ser82Asn variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Ser82Asn variant in TCF4 is classified as likely benign based on the ACMG/AMP criteria (BS2, BP4). (TCF4 specifications v.3; approved on 8/30/2024) |
Gene |
RCV001755142 | SCV001995995 | uncertain significance | not provided | 2019-09-17 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV002077195 | SCV002332946 | benign | Pitt-Hopkins syndrome | 2022-01-13 | criteria provided, single submitter | clinical testing |